News Agency
Men's Weekly

Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Phase 2 Clinical Trial

  • Written by PR Newswire

CHENGDU, China, April 18, 2023 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report that the Company has begun dosing patients in its Androgenetic Alopecia (AGA) Phase 2 clinical trial (NCT05802173) of topical TDM-105795 solution. This clinical trial in the AGA program...

Read more: Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Phase 2 Clinical Trial

Contactless Payments and the Rise of the Smart EFTPOS Machine

Introduction In the fast-evolving world of digital commerce, the way consumers pay for goods and services has undergone a dramatic transformation. Traditional cash registers are being replaced with sleek, intelligent systems capable of handling payments quickly and securely. Among these innovations... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion